weSRCH - Where Technology Meets Opportunity for in the Business of Science
Home»Latest 30days News on Medical, Biotech/Pharma - weSRCH
Click category or weSRCH domain below to read news from each weSRCH domain
High Tech:-Business, Consumer, Displays, IT, Mobile, Photo, Semiconductors
Medicine:-Biology, Biotech/Pharma, Equipment, Imaging, Implants, Practice Mngmnt, Therapy, Veterinary
Green Tech:-Battery & Fuel, Biomass, Environmental, Fossil/Nuclear, Lighting, Solar, Trans, Wind/Water/Geo
Business:-Companies, Entrepreneurial, IP/Law, Leadership & Strategy, Management, Sales & Marketing, Social Innovation

Latest News, Top News, Breaking News

Narrow Search   Exclude Keywords  
Total record(s) 1022 , Page No. 1 , Max 20 Records Per Page -
Page Nos. 1 2 3 4 5 6 7 8 9 10 .... Next >>
Astellas Pharma reaches agreement with US Department of Justice - Pharmaceutical Business Review
  Long Island Business News Astellas Pharma US CEO Masao Yoshida noted that the company cooperated fully with the US Government's review of this matter, and the company is pleased to have reache ....more | Save |  Share  Email 17th Apr 2014 
 
Apricus Biosciences' UK partner accepts first shipment of Vitaros - Pharmaceutical Business Review
  Published 17 April 2014. Apricus Biosciences has announced that Takeda Pharmaceuticals International, the company's partner in the UK, has accepted the first shipment of Vitaros, Apricus' nove ....more | Save |  Share  Email 17th Apr 2014 
 
Biotech starts recovery as ETFs finish day firmly in the black - MarketWatch (blog)
  For once, biotech wasn't the market's pariah at the close Wednesday. It wasn't even the butt of jokes in the health-care sector. The troubled sector that has given back virtually all the gains obtained durin ....more | Save |  Share  Email 17th Apr 2014 
 
Anti social? Big Pharma balks at US FDA social media guidance - In-PharmaTechnologist.com
  In-PharmaTechnologist.com Comments from Novartis, Eli Lilly and Pfizer revealed that industry is taking serious issue with some aspects of the draft guidance from the US FDA on social media and promotional material ....more | Save |  Share  Email 17th Apr 2014 
 
Pacira Pharmaceuticals Announces Timing for First Quarter 2014 Financial ... - The Herald | HeraldOnline.com (press release)
  PARSIPPANY, N.J. - Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX) today announced that financial results for the company's first quarter ended March 31, 2014, will be released b ....more | Save |  Share  Email 17th Apr 2014 
 
Once a Notorious Short Seller, Martin Shkreli Now Sees a Future in Biotech - Businessweek
  Martin Shkreli doesn't sit still. Slouching in a modern black chair at the Manhattan offices of Retrophin (RTRX), the biotechnology company he started three years ago, he fiddles with a keyboard connected to a ....more | Save |  Share  Email 17th Apr 2014 
 
Shasun Pharmaceuticals gains as PE investor takes minority stake in JV firm - Business Standard
  Moneycontrol.com Shasun Pharmaceuticals said that Ascent Capital Advisors India, a private equity investor has taken a minority stake in Alivira Animal Health. Alivira Animal Health is a joint venture between ....more | Save |  Share  Email 17th Apr 2014 
 
Antineutrophil Cytoplasm Antibody-Associated Vasculitis - Medscape
  Medscape Clinical trials evaluating mycophenolate mofetil as remission induction therapy, gusperimus, belimumab and complement factor C5a inhibition are also ongoing, and many other potential candidates are being investigated ....more | Save |  Share  Email 16th Apr 2014 
 
Local boy raising money to fight diabetes - KRCRTV.COM
  KRCRTV.COM A local 8-year-old is on a mission to raise some money for type one diabetes research. More than 50 children are competing to design an National Hot Rod Association funny car. The winner will travel to see his or her design featured at a ....more | Save |  Share  Email 16th Apr 2014 
 
Study: Diabetic Heart Attacks and Strokes Falling - ABC News
  SFGate In the midst of the diabetes epidemic, a glimmer of good news: Heart attacks, strokes and other complications from the disease are plummeting. Over the last two decades, the rates of heart attacks and strokes among diabetics fell by mor ....more | Save |  Share  Email 16th Apr 2014 
 
ModernGraham Annual Valuation Of Regeneron Pharmaceuticals - Seeking Alpha
  By using the ModernGraham method one can review a company's historical accomplishments and determine an intrinsic value that can be compared across industries. What follows is a specific look at how Regeneron Pharmaceuticals ....more | Save |  Share  Email 16th Apr 2014 
 
Heart Attacks, Strokes Related to Type 2 Diabetes Drop Dramatically - TIME
  The rates of type 2 diabetes-related complications, like heart attacks, kidney failure, strokes, and amputations, have significantly dropped in the last 20 years. In the new study, published in The New England Journal of Medicin ....more | Save |  Share  Email 16th Apr 2014 
 
Sexual dysfunction biotech Vyrix Pharmaceuticals files for a $30 million IPO - NASDAQ
  Vyrix Pharmaceuticals, a biotech developing an oral treatment for premature ejaculation, filed on Wednesday with the SEC to raise up to $30 million in an initial public offering. The Greenwood Village, CO-based compan ....more | Save |  Share  Email 16th Apr 2014 
 
Study: Diabetes May Be Increasing, But Another Danger Is Decreasing - News One
  NEW YORK (AP) - In the midst of the diabetes epidemic, a glimmer of good news: Heart attacks, strokes and other complications from the disease are plummeting. Over the last two decades, the rates of heart attacks and strokes ....more | Save |  Share  Email 16th Apr 2014 
 
Diabetes Complications Show Sharp Decline, Report Finds - New York Times
  Chron.com Federal researchers on Wednesday reported the first broad national picture of progress against some of the most devastating complications of diabetes, which affects millions of Americans, finding that rates of heart attac ....more | Save |  Share  Email 16th Apr 2014 
 
Diabetes-Related Problems Have Decreased Over Last 20 Years - Huffington Post
  Rates of certain serious, diabetes-related health problems have decreased substantially in the last two decades, according to a new study from the Centers for Disease Control and Prevention. Between 1990 and 2010, the rate of ....more | Save |  Share  Email 16th Apr 2014 
 
Diabetes Cases Rise in U.S. as Complication Rate Declines - Bloomberg
  Improved preventative care for diabetes has cut the rate of serious complications such as heart attack and stroke over the past 20 years in the U.S. while the number Americans diagnosed with the disease continues to rise, a governmen ....more | Save |  Share  Email 16th Apr 2014 
 
Diabetes Mellitus: Does Exercise Help? - Guardian Liberty Voice
  Guardian Liberty Voice Physicians and dietitians have often encouraged and prescribed exercise as a treatment to manage diabetes mellitus. Even though the World Health Organization suggests that regular physical activity can prevent or del ....more | Save |  Share  Email 16th Apr 2014 
 
Dicerna Pharmaceuticals Initiates Phase 1 Study of DCR-MYC in Patients with ... - The Herald | HeraldOnline.com (press release)
  WATERTOWN, Mass. - Dicerna Pharmaceuticals, Inc. (NASDAQ: DRNA), a leader in the development of RNAi-based therapeutics, today announced the initiation of a Phase 1 dose-escal ....more | Save |  Share  Email 16th Apr 2014 
 
Dicerna Pharmaceuticals Initiates Phase 1 Study of DCR-MYC - Benzinga
  Dicerna Pharmaceuticals, Inc. (NASDAQ: DRNA), a leader in the development of RNAi-based therapeutics, today announced the initiation of a Phase 1 dose-escalating clinical study of DCR-MYC, (also known as DCR-M1711), in patients with ....more | Save |  Share  Email 16th Apr 2014 
 
Total record(s) 1022 , Page No. 1 , Max 20 Records Per Page -
Page Nos. 1 2 3 4 5 6 7 8 9 10 .... Next >>